Human medicines

Nutriflex

Recall | Medicines | 01/02/2012

The marketing authorization holder has informed its supplied customers in a letter dated 26.01.2012 that crystalline particles may be present in the…

Nutriflex Read more

Nutriflex

Recall | Medicines | 22/12/2011

The marketing authorization holder has informed its supplied customers in a letter dated December 21, 2011, that crystalline particles may be present…

Nutriflex Read more

Velcade

Recall | Medicines | 22/12/2011

In a letter dated December 12, 2011, the distribution partner informed the institutional pharmacies supplied that the marketing authorization holder…

Velcade Read more

Vistide

Replacement | Medicines | 14/12/2011

The marketing authorization holder has informed its supplied customers by letter dated 14.12.2011 that the above mentioned batches have to be recalled…

Vistide Read more

Velcade

Recall | Medicines | 28/11/2011

The marketing authorization holder has informed the supplied customers by letter dated November 28, 2011, that a GMP inspection of the manufacturer…

Velcade Read more

Busilvex

Replacement | Medicines | 25/11/2011

The distributor has informed the supplied institutional pharmacies in a letter dated November 25, 2011, that a GMP inspection of the manufacturer Ben…

Busilvex Read more

Enapril

Replacement | Medicines | 16/11/2011

The marketing authorization holder informed its supplied customers in a letter dated November 14, 2011, that there was misinformation in the…

Enapril Read more

Nutriflex

Recall | Medicines | 08/11/2011

The marketing authorization holder informed its supplied customers in a letter dated November 7, 2011, that crystalline particles may be present in…

Nutriflex Read more

Meridol

Recall | Medicines | 04/11/2011

In a letter dated November 3, 2011, the distributor informed all pharmacies, dentists and the wholesalers supplied that all batches of this medicinal…

Meridol Read more

Xigris

Recall | Medicines | 27/10/2011

The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed its supplied customers by letter dated October…

Xigris Read more
Email

Further inquiry note